James Warren Huff Reata Pharmaceuticals Inc (RETA) insider trading activity

James Warren Huff is Chief Executive Officer of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of RETA, which is worth approximately $0. The most recent transaction as insider was on Sep 26, 2023, when has been sold 122,480 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James Warren Huff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 26 2023	SELL Sale (or disposition) back to the issuer	-	122,480 Reduced 100.0%	0 Class A Common Stock
Jul 06 2023	BUY Grant, award, or other acquisition	-	84,220 Added 40.75%	122,480 Class A Common Stock
Mar 02 2023	SELL Open market or private sale	$6,480,000 $86.4 p/Share	75,000 Reduced 67.47%	36,158 Class A Common Stock
Mar 01 2023	BUY Conversion of derivative security	-	75,000 Added 40.29%	111,158 Class A Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	47,025 Added 50.0%	47,025 Class A Common Stock
Nov 10 2020	SELL Open market or private sale	$11,369,750 $175.0 p/Share	64,970 Reduced 100.0%	0 Class A Common Stock
Nov 09 2020	SELL Open market or private sale	$2,921,226 $175.06 p/Share	16,687 Reduced 20.44%	64,970 Class A Common Stock

JWH

James Warren Huff

Chief Executive Officer

Plano, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RETA shares.

Notify only if

Value

Insider Trading

Get notified when an Reata Pharmaceuticals Inc insider buys or sells RETA shares.

Notify only if

Operation

Value

Type

News

Receive news related to REATA PHARMACEUTICALS INC

Track Activities on RETA

Account